201 related articles for article (PubMed ID: 8843316)
41. VT-1161 protects mice against oropharyngeal candidiasis caused by fluconazole-susceptible and -resistant Candida albicans.
Break TJ; Desai JV; Natarajan M; Ferre EMN; Henderson C; Zelazny AM; Siebenlist U; Hoekstra WJ; Schotzinger RJ; Garvey EP; Lionakis MS
J Antimicrob Chemother; 2018 Jan; 73(1):151-155. PubMed ID: 29040636
[TBL] [Abstract][Full Text] [Related]
42. [Antifungal susceptibility testing of commensal and pathogenic clinical isolates of oral Candida].
Zhao M; Zhou ZT
Shanghai Kou Qiang Yi Xue; 2006 Apr; 15(2):218-20. PubMed ID: 16685371
[TBL] [Abstract][Full Text] [Related]
43. Isolation, characterization and antifungal susceptibility pattern of Candida species causing oropharyngeal candidiasis in HIV positive patients.
Maninder J; Usha A
J Commun Dis; 2008 Sep; 40(3):177-81. PubMed ID: 19245155
[TBL] [Abstract][Full Text] [Related]
44. Genetic dissimilarity of two fluconazole-resistant Candida albicans strains causing meningitis and oral candidiasis in the same AIDS patient.
Berenguer J; Diaz-Guerra TM; Ruiz-Diez B; Bernaldo de Quiros JC; Rodriguez-Tudela JL; Martinez-Suarez JV
J Clin Microbiol; 1996 Jun; 34(6):1542-5. PubMed ID: 8735114
[TBL] [Abstract][Full Text] [Related]
45. In vitro activity of rilopirox against fluconazole-susceptible and fluconazole-resistant Candida isolates from patients with HIV infection.
Nenoff P; Taneva E; Pfeil B; Oswald U; Haustein UF
Mycoses; 1999 Apr; 42(1-2):55-60. PubMed ID: 10394849
[TBL] [Abstract][Full Text] [Related]
46. Persistent oral candidosis by non-albicans Candida strains including Candida glabrata in a human immunodeficiency virus-infected patient observed over a period of 6 years.
Hoegl L; Thoma-Greber E; Röcken M; Korting HC
Mycoses; 1998; 41(7-8):335-8. PubMed ID: 9861840
[TBL] [Abstract][Full Text] [Related]
47. Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar candida screening and susceptibility testing of isolates.
Kirkpatrick WR; Revankar SG; Mcatee RK; Lopez-Ribot JL; Fothergill AW; McCarthy DI; Sanche SE; Cantu RA; Rinaldi MG; Patterson TF
J Clin Microbiol; 1998 Oct; 36(10):3007-12. PubMed ID: 9738058
[TBL] [Abstract][Full Text] [Related]
48. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.
Khedri S; Santos ALS; Roudbary M; Hadighi R; Falahati M; Farahyar S; Khoshmirsafa M; Kalantari S
Lett Appl Microbiol; 2018 Oct; 67(4):392-399. PubMed ID: 30019443
[TBL] [Abstract][Full Text] [Related]
49. Correlation between antifungal susceptibility testing of Candida isolates from patients with HIV infection and clinical results after treatment with fluconazole.
Ruhnke M; Eigler A; Engelmann E; Geiseler B; Trautmann M
Infection; 1994; 22(2):132-6. PubMed ID: 8070927
[TBL] [Abstract][Full Text] [Related]
50. Efficacy of melaleuca oral solution for the treatment of fluconazole refractory oral candidiasis in AIDS patients.
Jandourek A; Vaishampayan JK; Vazquez JA
AIDS; 1998 Jun; 12(9):1033-7. PubMed ID: 9662200
[TBL] [Abstract][Full Text] [Related]
51. Clearance of a fluconazole-resistant Candida albicans strain after switching antifungal therapy and initiation of triple therapy for HIV infection.
Ruhnke M; Adler A; Müller FM
Clin Microbiol Infect; 2000 Apr; 6(4):220-3. PubMed ID: 11168112
[No Abstract] [Full Text] [Related]
52. Risk factors for fluconazole-resistant candidiasis in human immunodeficiency virus-infected patients.
Maenza JR; Keruly JC; Moore RD; Chaisson RE; Merz WG; Gallant JE
J Infect Dis; 1996 Jan; 173(1):219-25. PubMed ID: 8537662
[TBL] [Abstract][Full Text] [Related]
53. Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance.
Sangeorzan JA; Bradley SF; He X; Zarins LT; Ridenour GL; Tiballi RN; Kauffman CA
Am J Med; 1994 Oct; 97(4):339-46. PubMed ID: 7942935
[TBL] [Abstract][Full Text] [Related]
54. Prevalence of fluconazole-resistant strains of Candida albicans in otherwise healthy outpatients.
Haberland-Carrodeguas C; Allen CM; Beck FM; Buesching WJ; Koletar SL; Sundstrom P
J Oral Pathol Med; 2002 Feb; 31(2):99-105. PubMed ID: 11896831
[TBL] [Abstract][Full Text] [Related]
55. Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis.
Redding S; Smith J; Farinacci G; Rinaldi M; Fothergill A; Rhine-Chalberg J; Pfaller M
Clin Infect Dis; 1994 Feb; 18(2):240-2. PubMed ID: 8161633
[TBL] [Abstract][Full Text] [Related]
56. Persistence of oropharyngeal Candida albicans strains with reduced susceptibilities to fluconazole among human immunodeficiency virus-seropositive children and adults in a long-term care facility.
Makarova NU; Pokrowsky VV; Kravchenko AV; Serebrovskaya LV; James MJ; McNeil MM; Lasker BA; Warnock DW; Reiss E
J Clin Microbiol; 2003 May; 41(5):1833-7. PubMed ID: 12734213
[TBL] [Abstract][Full Text] [Related]
57. [Clinical fluconazole and itraconazole resistance of oro-gastrointestinal candidiasis in a patient with AIDS].
Tebbe B; Boyvat A; Geilen CC; Wölfer LU; Seibold M; Orfanos CE
Hautarzt; 1996 Feb; 47(2):136-9. PubMed ID: 8868459
[TBL] [Abstract][Full Text] [Related]
58. Evolution of antifungal susceptibility among Candida species isolates recovered from human immunodeficiency virus-infected women receiving fluconazole prophylaxis.
Vazquez JA; Peng G; Sobel JD; Steele-Moore L; Schuman P; Holloway W; Neaton JD
Clin Infect Dis; 2001 Oct; 33(7):1069-75. PubMed ID: 11528582
[TBL] [Abstract][Full Text] [Related]
59. Assessment of therapeutic response of oropharyngeal and esophageal candidiasis in AIDS with use of a new clinical scoring system: studies with D0870.
Hood SV; Hollis S; Percy M; Atkinson G; Williams K; Denning DW
Clin Infect Dis; 1999 Mar; 28(3):587-96. PubMed ID: 10194083
[TBL] [Abstract][Full Text] [Related]
60. Fungicidal efficacy of various honeys against fluconazole-resistant Candida species isolated from HIV
Shokri H; Sharifzadeh A
J Mycol Med; 2017 Jun; 27(2):159-165. PubMed ID: 28159362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
